Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA). (Q40995768)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

juvenile rheumatoid arthritis

7 March 2020

main subject

adalimumab

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Johannes-peter Haas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

7

Kirsten Minden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Martina Niewerth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Hans-Iko Huppertz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Angela Zink

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Gerd Horneff

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

English

0 references

publication date

29 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

Annals of the Rheumatic Diseases

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

855-861

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Factors associated with treatment response to etanercept in juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

The German etanercept registry for treatment of juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Marginal structural models and causal inference in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Experiences with tumour necrosis factor-{alpha} inhibitors in patients with juvenile idiopathic arthritis: Hungarian data from the National Institute of Rheumatology and Physiotherapy Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Infections during low-dose methotrexate treatment in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Juvenile idiopathic arthritis and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Rates of malignancy associated with juvenile idiopathic arthritis and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Adalimumab in the therapy of uveitis in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Clinical review: Anti-TNFalpha therapies in uveitis: perspective on 5 years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-ANNRHEUMDIS-2014-206747

10.1136/ANNRHEUMDIS-ANNRHEUMDIS-2014-206747

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25926155%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference